Heart disease is the leading cause of death in the U.S., and for years doctors recommended older adults take a daily aspirin ...

Heart disease is the leading cause of death in the US, and for years doctors recommended older adults take a daily aspirin as a preventative measure. But now medical guidelines have changed on daily ...

Recognizing this point should cause us to resist drawing conclusions regarding aspirin use in patients with heart failure - even those with concomitant coronary artery disease - from data ...

As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

Heart disease is the leading cause of death in the U.S., and for years, doctors recommended that older adults take a daily aspirin as a preventive measure. But doctors now say it may be doing more ...

A Danish study reveals a significant link between low-dose aspirin use and higher anemia rates among older adults.

The Ivy bleeding times before and two hours after 1 gm of aspirin in 14 patients with mild hemophilia A, 2 with mild hemophilia B, 3 with PTA deficiency, and 3 with established or suspected von ...

Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a post hoc analysis carried out in the ...

Some people might reach for a bottle of aspirin to ease pain. But the over-the-counter medication offers more than simply inflammation relief. It may provide heart benefits, too. Indeed ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

From bone to heart health, aspirin has been linked to all kinds of benefits through the years – though many of these benefits have since been debunked. But according to a recent study ...

The findings of this post hoc analysis suggest that both apixaban and aspirin may be effective in preventing adverse clinical outcomes in patients with a history of cancer and cryptogenic stroke.